A 37-year-old woman presented in 1993 with unstable angina. She had a history of hypertension, hypercholesterolaemia, tobacco use and family history of cardiovascular disease. She underwent a coronary angiogram (CA)…
An 81-year-old hypertensive woman underwent dual chamber permanent pacemaker implantation for sinus node disease at another hospital. Both atrial and ventricular leads were active fixation leads (Tendril ST Optim 1888TC,…
A 62-year-old man presented with severe pacemaker endocarditis after conservative treatment (pacemaker replacement and partial system removal, contralateral pacemaker implantation) in the context of pocket infection. This strategy leads to…
A 24-year-old man was admitted with stab wounds to the left anterior chest and profuse blood loss. Clinical examination revealed hypotension and tachycardia related to cardiac tamponade. He presented a…
Summary The prevalence of congenital heart disease among adults in Europe, or in any country in Europe, is not known. This is due to a lack of agreement on the…
Summary The relevance of electrical and mechanical dyssynchrony has been demonstrated in heart failure with reduced ejection fraction. Preserved ejection fraction is present in as many as 50% of patients…
Summary Background Flow cytometry has shown levels of platelet-derived microparticles (PMPs) and endothelial-derived microparticles (EMPs) to be elevated in deep-vein thrombosis. Cardiovascular risk factors can also contribute to hypercoagulability due…
Summary Background Treatment of atrial fibrillation (AF) by radiofrequency or cryoballoon ablation requires good sedation and effective analgesia to be carried out safely and successfully. Aim To compare analgesic and…
Summary Background Limited French data are available for the different clinical types (paroxysmal, persistent and permanent) of atrial fibrillation and their comorbidities (AF). Aims To provide contemporary insights into the…
Summary Background International guidelines recommend long-term use of evidence-based treatment (EBT) combining beta-blockers, aspirin/clopidogrel, statins and either angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs) after a myocardial infarction (MI),…
